|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
5R01CA185357-04
|
$398,393
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
3P01CA151135-05S1
|
$300,001
|
AMBROSONE, CHRISTINE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$519,415
|
Ambs, Stefan
|
CCR (NCI)
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
2/2 The GUIDE Cancer Research Training Project
|
3P20CA202907-03S1
|
$52,412
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
2/2 The GUIDE Cancer Research Training Project
|
5P20CA202907-03
|
$174,056
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA042014-28S1
|
$249,799
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S2
|
$123,315
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S3
|
$46,117
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S4
|
$59,999
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S5
|
$113,563
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S6
|
$75,709
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S7
|
$75,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S8
|
$166,146
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
SPORE: Brain Tumore SPORE Grant
|
5P50CA097257-15
|
$2,300,000
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Returning genetic research panel results for breast cancer susceptibility
|
5R01CA190871-04
|
$298,197
|
BRADBURY, ANGELA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Great Lakes New England Clinical Validation Center
|
5U01CA086400-17
|
$1,315,798
|
BRENNER, DEAN
|
UNIVERSITY OF MICHIGAN
|
|
Georgia NCI Community Oncology Research Program (NCORP)
|
5UG1CA189997-04
|
$1,304,055
|
CANTUARIA, GUILHERME
|
NORTHSIDE HOSPITAL ATLANTA
|
|
Risk and penetrance of mutations from breast cancer testing panels.
|
5R01CA192393-04
|
$1,263,145
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
BRCA1 and BRCA2 missense mutations and breast cancer risk
|
5U01CA116167-10
|
$527,128
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S1
|
$60,000
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S2
|
$75,000
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S3
|
$749,911
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-43
|
$5,815,389
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Antibody-based therapeutics and vaccines against AIDS
|
ZIA BC 011155
|
$220,413
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
Human CYP2A and respiratory tract xenobiotic toxicity
|
5R01CA092596-12
|
$358,935
|
DING, XINXIN
|
SUNY POLYTECHNIC INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA091842-16S1
|
$122,824
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-16S2
|
$243,947
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-16
|
$4,305,712
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
Cancer Center Support Grant
|
3P30CA015704-42S1
|
$249,999
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S2
|
$125,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S3
|
$58,085
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S4
|
$70,220
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-21
|
$372,400
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Molecular Predictive Testing in Ocular Melanoma
|
2R01CA125970-11
|
$561,808
|
HARBOUR, JAMES
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A National Curriculum in Cancer Genomics for Residents and Medical Students
|
2R25CA168544-06
|
$255,425
|
HASPEL, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|